Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9Lu Liang, Xiyong Yu, Zhijun Chen et al.|Acta Pharmacologica Sinica|2022Cited by 30
Development of Novel NKp46-based Chimeric Antigen Receptors for Cancer ImmunotherapyBo Zou, Qibin Liao, Mei‐Yan Xu et al.|Journal of Nanotechnology Research|2025Cited by 0